NOxBOXi Nitric Oxide Delivery System recalled for newborns, neonates
July 14th 2023The FDA has identified NOxBOX Ltd’s recall of NOxBOXi Nitric Oxide Delivery System as a Class I recall. Affected devices to the newborn and neonate patient populations can cause nitric oxide therapy interruptions because of a check valve misalignment. As of July 13, 2023, no injuries or deaths have been reported according to the federal agency.
Advancements in FDA approvals for pediatric obesity treatment
GLP-1 receptor agonists, used to treat diabetes, are now also being used for obesity in children and adolescents.
Friction-induced blistering on a child’s feet
July 14th 2023You are called to the hospital nursery to evaluate a healthy full-term newborn boy who developed painful flaccid blisters and erosions on the tops of his feet and ankles shortly after birth. His mother had a history of similar recurrent skin lesions that healed with scarring. She also had oral and gastrointestinal tract involvement. What's the diagnosis?
EPA proposes new lead paint standards for pre-1978 buildings, child facilities
July 13th 2023To better protect children from its several negative effects, the Environmental Protection Agency (EPA) has proposed stricter requirements for lead-based paints in pre-1978 buildings and childcare facilities.
Study evaluates system for pediatric T1D management compliance
July 11th 2023To help teens with the difficult emotional and physical weight of managing this disease, numerous tools, technology platforms, and interventions have been developed. A research team recently published a review of one of these tools, a 40-year-old automated messaging system.
Deep learning models can assist in clinical suspicion of abusive head trauma
July 10th 2023Deep learning models have the potential to assist clinicians in determining suspicion for abusive head trauma (AHT) by screening pediatric head computed tomography (CT) images for retinal hemorrhage, according to a recent study.
Study suggests rising obesity prevalence may have altered perceptions of healthy body weights
July 7th 2023An analysis of data from nearly 750,000 adolescents from more than 40 countries offers insight into the changing, and possibly inaccurate, perceptions of healthy body weight among younger people since the turn of the century.
Novavax as a second dose: A potential game changer for adolescent COVID-19 vaccination
July 7th 2023The findings showed that heterologous vaccination, or mixing different vaccines, was safe and effective, with the Novavax vaccine (NVX-CoV2373) providing enhanced protection against the Omicron variant.
Posttraumatic headache phenotype associated with symptom burden, quality of life after concussion
July 7th 2023Study investigators found that children with posttraumatic migraine symptoms after a concussion had higher symptom burden and lower quality of life 3 months after the injury compared to those with nonmigraine headache.
Oral immunotherapy shown to be effective in desensitization for egg, milk, peanut allergy
July 6th 2023New data on oral immunotherapy to food allergens shows promise for the treatment, though more information with standard interventions and regimens is needed to gain certainty on the efficacy and safety.
How health care institutions can help fight climate change
July 6th 2023Sandra H. Jee, MD, MPH, professor of pediatrics, director, Center for Community Health and Prevention, Finger Lakes Children’s Environmental Health Center, University of Rochester Medical Center, addresses how health care institutions contribute to the climate crisis. In this Contemporary Pediatrics® interview, Jee provides practical examples health care professionals can use in their offices to better help the environment, which can better help patients in the long term.
How to prevent children from accidental e-liquid exposures
July 5th 2023To combat instances of e-liquid exposure and accidental ingestions among children, the FDA is offering tips for best storage and safety practices for those that regularly use and handle these products, according to a recent press release.
CAP-1002 demonstrates positive phase 2 results to treat Duchenne muscular dystrophy
June 30th 2023Improvement in the left ventricular ejection fraction (LVEF) and statistically significant benefit in the Performance of the Upper Limb (PUL v2.0) scale were observed following 2 years of CAP-1002 treatment in Duchenne muscular dystrophy (DMD) patients.
FDA accepts NDA for givinostat to treat Duchenne muscular dystrophy
June 29th 2023According to Italfarmaco Group, a New Drug Application (NDA) for givinostat has been accepted and granted priority review by the FDA to treat Duchenne muscular dystrophy (DMD) patients, following positive topline phase 3 trial results.